Promising Advances in NEC Research and Treatment
NETCast
00:00
Navigating Neuroendocrine Carcinomas
This chapter explores the biological and clinical differences between pulmonary and extrapulmonary neuroendocrine carcinomas, emphasizing their unique presentations and management strategies. It covers advancements in treatment, including immune checkpoint inhibitors and T-cell engagers like tarlatumab, noting their potential to improve patient outcomes. The discussion also highlights patient-centered care and the importance of tumor profiling in shaping effective therapeutic approaches.
Transcript
Play full episode
